92 studies found for:    Fabry Disease
Show Display Options
Rank Status Study
1 Recruiting Canadian Fabry Disease Initiative (CFDI) Enzyme Replacement Therapy (ERT) Study
Condition: Fabry Disease
Interventions: Drug: agalsidase alfa (Replagal®) and agalsidase beta (Fabrazyme®);   Drug: Enzyme Replacement Therapy (ERT)
2 Recruiting The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease
Conditions: Fabry Disease;   Fabry´s Disease;   Anderson-Fabry Disease
Intervention:
3 Recruiting Establishment of Biomarkers for Fabry Disease
Condition: Fabry Disease
Intervention: Other: Fluorescein angiography
4 Recruiting Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta
Condition: Fabry Disease
Intervention:
5 Recruiting A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Iohexol
6 Unknown  Detection of Fabry Disease in Chronic Renal Failure Patients in Area Provence - Alpes - Côte d'Azur
Condition: Fabry Disease
Intervention: Other: micromethod from samples taken from blood spots on filter paper
7 Recruiting Androgenetic Alopecia in Fabry Disease
Condition: Fabry Disease
Intervention:
8 Completed Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients
Condition: Cerebrovascular Accident
Intervention: Other: No intervention
9 Recruiting Fabry Disease Registry
Condition: Fabry Disease
Intervention:
10 Recruiting Enzyme Replacement Therapy in Fabry Disease
Condition: Fabry Disease
Intervention: Other: Biochemical analyses.
11 Completed Data Collection in Women With Fabry Disease
Condition: Fabry Disease
Intervention:
12 Completed PET Scans in Normal Volunteers and Patients With Fabry Disease
Conditions: Fabry Disease;   Healthy
Intervention:
13 Completed Alpha-Galactosidase A Replacement Therapy for Fabry Disease
Condition: Fabry Disease
Intervention: Drug: DRX005B
14 Completed An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Replagal
15 Completed Registry of Fabry Disease - A Multicenter Observational Study
Condition: Fabry Disease
Intervention:
16 Completed Dosing Study of Replagal in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Replagal
17 Recruiting Pulmonary Disease and Exercise Tolerance in Boys With Fabry Disease
Condition: Fabry Disease
Intervention:
18 Recruiting Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease
Conditions: Fabry Disease;   Neuropathic Pain
Interventions: Drug: Gabapentin;   Drug: placebo
19 Completed Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity
Condition: Fabry Disease
Intervention:
20 Completed Alternative Dosing and Regimen of Replagal to Treat Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Replagal

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years